Q1 |
Papers that had schizophrenia as some of the subject types, along with resting state fMRI, and any cognitive measure. |
Schizophrenia AND (RestingStateImaging OR RestingStateImagingProtocol) AND NeurocognitiveTest
|
31 |
15 (48.39%) |
Q2 |
Papers that had healthy controls (“No known disorder”), and resting state fMRI. |
NoKnownDisorder AND (RestingStateImaging OR RestingStateImagingProtocol) |
40 |
27 (67.50%) |
Q3 |
Papers that had some measure of impulsivity, and structural imaging (T1-weighted) data. |
ImpulsivityScale AND (T1WeightedImaging OR T1WeightedImagingProtocol) |
26 |
12 (46.13%) |
Q4 |
Papers that had subjects with alcohol use disorder, a personality questionnaire, and a task-based fMRI method. |
AlcoholAbuse AND PersonalityRatingScale AND (TaskParadigmImaging OR TaskParadigmImagingProtocol) |
32 |
12 (37.50%) |
Q5 |
Papers that had subjects with cannabis use disorder, neurocognitive assessment, and resting-state fMRI. |
CannabisAbuse AND NeurocognitiveTest AND (RestingStateImaging OR RestingStateImagingProtocol) |
30 |
8 (26.66%) |